Close

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $130 at BofA Securities; 'beatable Roctavian expectations'

June 10, 2020 7:13 AM EDT Send to a Friend
BofA Securities analyst Geoff Meacham raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $130.00 (from $120.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login